Carboxymethyl chitosan-TK resistant starch complex ameliorates type 2 diabetes by regulating the gut microbiota

Int J Biol Macromol. 2023 Dec 31;253(Pt 3):126930. doi: 10.1016/j.ijbiomac.2023.126930. Epub 2023 Sep 17.

Abstract

Carboxymethyl chitosan and resistant starch exhibit good performance in diabetes regulation. We prepared carboxymethyl chitosan - resistant starch complex. Test the properties of composite resistant starch by using X-ray diffraction, water contact angle, infrared spectroscopy, and scanning electron microscopy, interactions with intestinal microbiota and mouse experiments were also conducted. The results indicated that the composite resistant starch had a good effect on promoting the proliferation of probiotics on Bifidobacterium and a significant inhibitory effect on Escherichia coli than resistant starch (P < 0.05). After administration, the water intake and weight of diabetic mice were significantly reduced. The blood glucose of diabetic mice was also reduced, and oral glucose tolerance showed that the glucose degradation rates of composite resistant starch were significantly improved compared to model mice. Cholesterol, triglycerides, high-density lipoprotein and low-density lipoprotein were significantly lower than those in the diabetes group (P < 0.05). The diversity of the gut microbiota was also proven.

Keywords: Carboxymethyl chitosan; Diabetes mice; Gut microbiota; Resistant starch; Trichosanthes kirilowii.

MeSH terms

  • Animals
  • Chitosan* / chemistry
  • Chitosan* / pharmacology
  • Diabetes Mellitus, Experimental* / drug therapy
  • Diabetes Mellitus, Type 2* / drug therapy
  • Gastrointestinal Microbiome*
  • Mice
  • Resistant Starch / pharmacology
  • Starch / chemistry

Substances

  • Resistant Starch
  • Starch
  • Chitosan